MIAMI, April, 24, 2024 /PRNewswire/ --Getlabs,
the nationwide leader in at-home diagnostics collection, has joined
forces with Inocras, a leading AI-driven whole genome testing
company that empowers patients with critical genetic insights for
cancer and rare diseases.
Getlabs' mission is to save lives by delivering outstanding
healthcare to everyone. The company has redesigned the lab
experience around patients, allowing them to book lab sample
collections conveniently and comfortably from their homes, creating
greater accessibility and convenience in their care process.
Inocras provides whole genome sequencing tests, which deliver
patients deep insights into their cancer and rare disease by
providing comprehensive and detailed analyses of an individual's
genetic composition. The company's innovative digital service
platform offers patients a seamless end-to-end experience, allowing
them to request a test order, book at-home sample collections with
the help of the Getlabs partnership, and receive test results with
genetic counseling support.
By embedding Getlabs' at-home lab collection services within
Inocras's intuitive end-to-end patient testing process, this
partnership promises a unique and enhanced experience for patients,
who will benefit from its convenience and efficiency.
"We are thrilled to embark on this partnership with Inocras,"
said Kyle Michelson, CEO of Getlabs.
"Together, we are empowering patients to take control of their
health journey by providing them with access to lab collection
services without having to travel to or sit in a waiting room."
Inocras Chief Strategy Officer, Rebecca
Jang, remarks, "We are thrilled to launch our whole genome
diagnostics products, CancerVision and RareVision. They will
provide a more holistic view on patients' disease and health,
presenting not only commonly known mutations but also ultra rare
and complicated mutations. Patients can get cutting-edge
diagnostics through our patient-centric digital service platform.
Our partnership with Getlabs is one of many important steps in
bringing patients the best experience possible."
The partnership between Getlabs and Inocras represents a
powerful collaboration between two industry leaders committed to
enhancing the patient experience through accessibility, convenience
and efficiency. As both organizations continue to push beyond the
boundaries of healthcare technology, patients can look forward to a
future where access to whole genome sequencing is easier and more
convenient than ever before.
About Getlabs: Getlabs is the nationwide leader for at-home
diagnostics. Healthcare organizations use our all-in-one platform
to dispatch skilled medical specialists to their patients and
collect labs, vitals, and advanced diagnostics. By partnering with
Getlabs, providers can expand access to care, improve adherence,
and make informed medical decisions remotely. Learn more
Inocras Inc. (formerly Genome Insight, Inc) is a pioneering
provider of whole genome sequencing and analytics services for
cancer and rare diseases. The company is dedicated to unlocking the
potential of genomic data to enable precision health for everyone.
To learn more, visit Inocras.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/getlabs-and-inocras-partner-to-create-a-seamless-patient-experience-for-cancer-and-rare-disease-testing-302126342.html
SOURCE Getlabs